Clinical Trial: Efficacy of Crisaborole 2% Ointment Versus Tacrolimus 0.1% Ointment in the Treatment of Intertriginous and/or Anogenital Psoriasis: A Prospective Randomized Controlled Study.

U.S., Oct. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07892339) titled 'Efficacy of Crisaborole 2% Ointment Versus Tacrolimus 0.1% Ointment in the Treatment of Intertriginous and/or Anogenital Psoriasis: A Prospective Randomized Controlled Study.' on Oct. 17.

Brief Summary: The goal of this clinical trial is to learn if topical application of crisaborole 2% ointment can treat flexural and/or genital psoriasis in adult patients of both genders. It will also learn about the safety of crisaborole 2% ointment.

The main questions it aims to answer is:

* Does crisaborole 2% ointment work effectively in flexural and/or genital psoriasis in adults?

* is crisaborole 2% ointment well tolerated in flexural and/...